It seems that the new from the Europe has given the much needed push to the financial market as the Nikkei share average was seen edging up by 2%. There have been doubts whether France and Germany would be able to divert the possible debt crisis going on, but with the latest round of talks coming end to a positive note, expectations have raised that something better is stored in future.
With the kind of movement being experienced, there are speculations that Nikkei would try to move from 8,800 to 9,000 for the next few days. As per latest reports, Nikkei moved up to 8,773.68, the highest mark being attained since Sept 16.
Moreover, Sony was seen moving up by 5.7% to 1,496 yen while Honda moved up by 5.5% to 2,347 yen.
In response to the movement, Ryota Sakagami, chief strategist at SMBC Nikko Securities said: “Credit spreads (for banks) are still far from tight. It’s hard to expect the Nikkei to move above 9,000 and stay there. A fall below 8,500 is more likely”.
Post-seeing the turn of events in Europe, sentiments in the market are expected to take a new shift in the coming time. It’s largely expected that a comprehensive European bank package could heal the damage done in the market so far.
In a Tuesday announcement, Supergiant Games studio’s founder Greg Kasavin said that the studio — the creator of games like Bastion and Transistor — has plans underway to launch a new action-RPG in 2017.
According to the announcement,…
A new study by the Massachusetts Institute of Technology (MIT) has revealed that Istanbul lies…
The Michael J Fox Foundation is aiming to test wearable sensors in smart watches made by Intel’s…
Electric vehicle manufacturer Tesla has said in a recent announcement that it is now offering free trials of its autopilot software on Model S and Model X cars. The free trials give the owners of Model S and Model X cars a chance to test…
In January, trade surplus of Germany decreased since plunge in imports was more than a drop in…
On Tuesday, tech giant Google released latest to show how much of its online traffic is…
German drugmaker Merck said that its experimental cancer medicine evofosfamidehas failed in the last stage of clinical tests due to which it won’t seek regulatory approval for its treatment.
On Monday, Darmstadt, Germany-based Merck said…
In a Tuesday announcement, Adobe revealed that it has...
With the computer business having witnessed steep losses...
In a scenario where the government of the nations are...
After the event that was the 'hot-news' of the week, the...
© 2024 AustrianTribune